Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5271835
Max Phase: Preclinical
Molecular Formula: C44H71N17O11S4
Molecular Weight: 1142.43
Associated Items:
ID: ALA5271835
Max Phase: Preclinical
Molecular Formula: C44H71N17O11S4
Molecular Weight: 1142.43
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)C(=O)N1)C(=O)N[C@H]1CSSC[C@@H](C(N)=O)NC1=O
Standard InChI: InChI=1S/C44H71N17O11S4/c1-3-21(2)33(42(72)60-31-20-74-73-17-28(34(47)64)57-40(31)70)61-38(68)27(12-13-32(46)63)56-37(67)25(6-4-14-52-43(48)49)54-36(66)26(7-5-15-53-44(50)51)55-39(69)30-19-76-75-18-29(41(71)59-30)58-35(65)24(45)16-22-8-10-23(62)11-9-22/h8-11,21,24-31,33,62H,3-7,12-20,45H2,1-2H3,(H2,46,63)(H2,47,64)(H,54,66)(H,55,69)(H,56,67)(H,57,70)(H,58,65)(H,59,71)(H,60,72)(H,61,68)(H4,48,49,52)(H4,50,51,53)/t21-,24-,25-,26-,27-,28-,29-,30-,31-,33-/m0/s1
Standard InChI Key: JUJVYISGBQMPOK-JEKWBXCUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1142.43 | Molecular Weight (Monoisotopic): 1141.4402 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Brust A, Croker DE, Colless B, Ragnarsson L, Andersson Å, Jain K, Garcia-Caraballo S, Castro J, Brierley SM, Alewood PF, Lewis RJ.. (2016) Conopeptide-Derived κ-Opioid Agonists (Conorphins): Potent, Selective, and Metabolic Stable Dynorphin A Mimetics with Antinociceptive Properties., 59 (6): [PMID:26859603] [10.1021/acs.jmedchem.5b00911] |
Source(1):